Triamterene And Hydrochlorothiazide
Product Images NDC 53002-1252

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Triamterene And Hydrochlorothiazide (NDC 53002-1252). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure diagram displaying the molecular formula of the active ingredient associated with Triamterene and Hydrochlorothiazide. The diagram shows nitrogen atoms and aromatic rings characteristic of the chemical compound.*

FDA Label Image

Image 2

Chemical structure of Triamterene, showing the molecular arrangement including a benzene ring with attached chlorine, sulfonamide, sulfonyl, and amine groups.*

FDA Label Image

Label Image (Lbl530021252)

Triamterene and Hydrochlorothiazide 37.5-25 mg tablets packaging label from RPK Pharmaceuticals, Inc. The label indicates a supply of 30 tablets with instructions to take one tablet daily or as directed. It is identified as a prescription medication with NDC 53002-1252. The label includes barcode and lot information and highlights the combination of triamterene and hydrochlorothiazide as active ingredients.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.